您的位置:PharmaNews 行业信息 正文
内容搜索
热门内容
推荐内容
最新内容
反馈意见和建议

Federal Jury Finds Cornell University's Medical College Committed Fraud(3)
本文章共3692字,分3页,当前第3页,快速翻页:

Despite the outcome of the trial, Dr. Feldman is still disappointed by the lack of oversight of billions of taxpayer dollars awarded by the NIH to large academic institutions. He feels that this remains a larger, unresolved issue. "And being a federal whistleblower is not something you undertake without tremendous sacrifice. Whistleblowers have to be willing to risk their careers, lose many of their work and social relationships, and wait for many years for justice. In the end, prevailing certainly feels great and worth the cost to do the right thing."

Contact:

Michael J. Salmanson

Salmanson Goldshaw, P.C.

2 Penn Center, Suite 1230

Philadelphia, PA 19102

215-640-0594

 

 


SOURCE Salmanson Goldshaw, P.C.

 

转载自pharmaLive


 

 

点这里复制本页地址     发送给您QQ/MSN上的好友


相关文章

  Employment at NJ Biotechnology Companies

  Devax Receives CE Mark for the AXXESS Dr

  WILEX AG recommends shareholders not to

  VaxGen and diaDexus Complete Merger

  WuXi PharmaTech Well Positioned to Conti

Conatus Pharmaceuticals Acquires Pfizer'

Charles River Announces Mutual Terminati

USIBC Salutes Abbott Laboratories for 10

药明康德出售搁浅 作价过高或成祸首

全球制药业R&D投入更趋理性

黑龙江研制中药壳聚糖复合药膜 可加速顽固性

重磅!抗生素政策再度收紧,集采下所剩不多

原研药与仿制药之争激烈,近40亿品种市场迎

本土中药CRO企业与跨国药企“牵手”,推动中

生物制剂集采真的来了!

相关评论

    
本文章所属分类:首页 行业信息